The U.S. Food and Drug Administration (FDA) on Monday approved AstraZeneca Plc's (NASDAQ:AZN) Imfinzi (durvalumab) in ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant ...

AstraZeneca’s Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in ...

The FDA has approved Imfinzi® (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of adult patients with MIBC.

Although radical cystectomy is an effective treatment for bladder cancer, it can have negative effects on urinary and sexual function. Lane et al. have performed nerve-sparing and reproductive ...

An NHS doctor has shared a video on TikTok claiming there is one thing you can do before surgery that will have a major difference to your outcome and help your recovery process ...

Imfinzi in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy ...

Cystoscopic tattooing provided clear intraoperative tumor localization, enabling precise resection and minimizing bladder wall loss. This approach addressed a key challenge of robotic bladder ...

OE, prior cystectomy (group 2 ... to determine how these procedures affect IVF outcomes. Because invasive surgery is often associated with postoperative reductions in fertility, including ...

The FDA has approved neoadjuvant durvalumab plus chemotherapy followed by adjuvant durvalumab after radical cystectomy in MIBC.